Bifogade filer
Kalender
Est. tid* | ||
2020-02-12 | - | X-dag kvartalsutdelning ORI 4.3126 |
2019-11-14 | - | X-dag kvartalsutdelning ORI 4.3126 |
2019-11-07 | - | Kvartalsrapport 2019-Q3 |
2019-09-30 | - | Extra Bolagsstämma 2019 |
2019-08-14 | - | X-dag kvartalsutdelning ORI 4.3126 |
2019-08-08 | - | Kvartalsrapport 2019-Q2 |
2019-05-10 | - | X-dag kvartalsutdelning ORI 4.3126 |
2019-05-09 | - | Årsstämma |
2019-05-09 | - | Kvartalsrapport 2019-Q1 |
2019-02-14 | - | X-dag kvartalsutdelning ORI 4.1922 |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-11-14 | - | X-dag kvartalsutdelning ORI 4.1004 |
2018-11-07 | - | Kvartalsrapport 2018-Q3 |
2018-08-14 | - | X-dag kvartalsutdelning ORI 4.174 |
2018-08-07 | - | Kvartalsrapport 2018-Q2 |
2018-05-08 | - | X-dag kvartalsutdelning ORI 14.7594 |
2018-05-04 | - | Årsstämma |
2018-05-04 | - | Kvartalsrapport 2018-Q1 |
2018-02-15 | - | Bokslutskommuniké 2017 |
2018-02-14 | - | X-dag kvartalsutdelning ORI 2.47 |
2017-11-14 | - | X-dag kvartalsutdelning ORI 2.4392 |
2017-11-08 | - | Kvartalsrapport 2017-Q3 |
2017-08-17 | - | Kvartalsrapport 2017-Q2 |
2017-08-14 | - | X-dag kvartalsutdelning ORI 2.395 |
2017-05-12 | - | X-dag kvartalsutdelning ORI 7.2357 |
2017-05-10 | - | Kvartalsrapport 2017-Q1 |
2017-05-09 | - | Årsstämma |
2017-02-16 | - | Kapitalmarknadsdag 2017 |
2017-02-16 | - | Bokslutskommuniké 2016 |
2017-02-14 | - | X-dag kvartalsutdelning ORI 2.4363 |
2016-11-14 | - | X-dag kvartalsutdelning ORI 1.9791 |
2016-11-11 | - | Kvartalsrapport 2016-Q3 |
2016-08-16 | - | Kvartalsrapport 2016-Q2 |
2016-05-18 | - | X-dag kvartalsutdelning ORI 0 |
2016-05-18 | - | Kvartalsrapport 2016-Q1 |
2016-05-17 | - | Årsstämma |
2016-05-17 | - | Kvartalsrapport 2016-Q1 |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-11-12 | - | Kvartalsrapport 2015-Q3 |
2015-08-13 | - | Kvartalsrapport 2015-Q2 |
2015-05-20 | - | X-dag kvartalsutdelning ORI 0 |
2015-05-19 | - | Årsstämma |
2015-05-08 | - | Kvartalsrapport 2015-Q1 |
2015-02-11 | - | Bokslutskommuniké 2014 |
2014-11-04 | - | Analytiker möte 2014 |
2014-11-04 | - | Kvartalsrapport 2014-Q3 |
2014-08-14 | - | Kvartalsrapport 2014-Q2 |
2014-05-20 | - | X-dag kvartalsutdelning ORI 2.2533 |
2014-05-19 | - | Extra Bolagsstämma 2014 |
2014-05-19 | - | Årsstämma |
2014-05-07 | - | Kvartalsrapport 2014-Q1 |
2014-02-14 | - | Bokslutskommuniké 2013 |
2013-11-12 | - | Analytiker möte 2013 |
2013-11-12 | - | Kvartalsrapport 2013-Q3 |
2013-08-15 | - | Kvartalsrapport 2013-Q2 |
2013-05-22 | - | X-dag ordinarie utdelning ORI 15.05 SEK |
2013-05-21 | - | Extra Bolagsstämma 2013 |
2013-05-21 | - | Årsstämma |
2013-04-25 | - | Kvartalsrapport 2013-Q1 |
2013-02-14 | - | Bokslutskommuniké 2012 |
2012-12-19 | - | Extra Bolagsstämma 2012 |
2012-10-25 | - | Kvartalsrapport 2012-Q3 |
2012-08-14 | - | Kvartalsrapport 2012-Q2 |
2012-05-22 | - | X-dag ordinarie utdelning ORI 15.77 SEK |
2012-05-21 | - | Årsstämma |
2012-04-27 | - | Kvartalsrapport 2012-Q1 |
2012-02-17 | - | Bokslutskommuniké 2011 |
2011-11-10 | - | Kvartalsrapport 2011-Q3 |
2011-08-10 | - | Kvartalsrapport 2011-Q2 |
2011-05-20 | - | X-dag ordinarie utdelning ORI 13.08 SEK |
2011-05-19 | - | Extra Bolagsstämma 2011 |
2011-05-19 | - | Årsstämma |
2011-05-04 | - | Kvartalsrapport 2011-Q1 |
2011-02-16 | - | Bokslutskommuniké 2010 |
2010-10-26 | - | Kvartalsrapport 2010-Q3 |
2010-08-11 | - | Kvartalsrapport 2010-Q2 |
2010-05-20 | - | X-dag ordinarie utdelning ORI 12.80 SEK |
2010-05-19 | - | Årsstämma |
2010-04-21 | - | Kvartalsrapport 2010-Q1 |
2010-02-10 | - | Bokslutskommuniké 2009 |
2009-10-23 | - | Kvartalsrapport 2009-Q3 |
2009-08-12 | - | Kvartalsrapport 2009-Q2 |
2009-05-20 | - | X-dag ordinarie utdelning ORI 13.65 SEK |
2009-05-19 | - | Årsstämma |
2009-04-23 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
Land | Schweiz |
---|---|
Sektor | Handel & varor |
Industri | Detaljhandel |
Oriflame is updating the market with preliminary unaudited key figures for the fourth quarter 2018, showing a shift in the geographical mix and maintaining a stable underlying profitability. Asia & Turkey recorded a sales decline during the quarter, while an improved sales momentum was seen in Latin America, Europe & Africa and CIS. Given the company's financial position and profitability, the Board of Directors has the intention to propose to the 2019 AGM a total dividend in line with last year's ordinary dividend.
- Local currency sales increased by 1% with a euro sales decrease of 3% to €370m (€380.1m, FY €1,319m).
- Operating margin amounted to 13.5% (14.8%, FY 11.3%), negatively impacted by around 140 bps from currencies, and operating profit amounted to €50m (€56.3m, FY €149m).
- Net profit amounted to €33 (€35.8m, FY €96m) and diluted EPS to €0.57 (€0.62, FY €1.68).
- The net debt at hedged values/EBITDA ratio amounted to 0.25 compared to -0.02 in 2017.
- Latin America: local currency sales increased by 6% (euro sales increase of 5%).
- Europe & Africa: local currency sales increased by 7% (euro sales increase of 7%).
- CIS: local currency sales increased by 5% (euro sales decrease of 2%).
- Asia & Turkey: local currency sales decreased by 8% (euro sales decrease of 13%).
Dividend proposal
Based on the preliminary unaudited results and financial position, and in line with the company's dividend policy, the Board of Directors has the intention to propose to the 2019 AGM a total dividend of €1.60 (to be compared with 2018 AGM €1.60 ordinary dividend + €1.00 extra ordinary dividend).
The company remains in a closed period until the full year-end report will be published on February 14, 2019 according to the company's financial calendar and policy.
For information, please contact:
Gabriel Bennet, Chief Financial Officer +41 798 263 769
Nathalie Redmo, Sr. Manager Investor Relations, +41 799 220 173
This information is inside information that Oriflame Holding AG is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:05 CET on January 18, 2019.
*IFRS - Clarifying information
The preliminary unaudited figures and comments above are excluding the impact of IFRS 15, IFRS 16 and related accounting alignments. The numbers are fully comparable with the 2017 reported figures.
Founded in 1967, Oriflame is a beauty company selling direct in more than 60 countries. Its wide portfolio of Swedish, nature-inspired, innovative beauty products is marketed through approximately 3 million independent Oriflame Consultants, generating annual sales of around €1.4 billion. Respect for people and nature underlies Oriflame's operating principles and is reflected in its social and environmental policies. Oriflame supports numerous charities worldwide and is a Co-founder of the World Childhood Foundation. Oriflame is a Swiss company group listed on the Nasdaq Stockholm Exchange. For more information about Oriflame, please visit www.oriflame.com.